Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38 alpha(MAPK) inhibitors in Werner syndrome cells

Davis, Terence. ORCID: https://orcid.org/0000-0003-2780-0262, Bagley, Mark Christopher, Dix, M. C., Murziani, Paola G. S., Rokicki, M. J., Widdowson, C. S., Zayed, J. M., Bachler, M. A. and Kipling, David Glyn 2007. Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38 alpha(MAPK) inhibitors in Werner syndrome cells. Bioorganic & Medicinal Chemistry Letters 17 (24) , pp. 6832-6835. 10.1016/j.bmcl.2007.10.036

Full text not available from this repository.

Item Type:	Article
Status:	Published
Schools:	Schools > Chemistry Schools > Medicine Schools > Pharmacy
ISSN:	0960-894X
Last Modified:	02 Mar 2025 14:55
URI:	https://orca.cardiff.ac.uk/id/eprint/5910

Citation Data

Cited 30 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item